CCIA
ORGO icon

Campbell & Co Investment Adviser’s Organogenesis Holdings ORGO Stock Holding History

Campbell & Co Investment Adviser’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-14,193
Closed -$46K – 935
2022
Q3 		$46K Buy
+14,193
New +$64.1K 0.01% 688
2022
Q2 		– Sell
-21,233
Closed -$162K – 856
2022
Q1 		$162K Buy
21,233
+4,633
+28% +$35.9K 0.04% 646
2021
Q4 		$153K Buy
16,600
+2,600
+19% +$27.6K 0.05% 564
2021
Q3 		$199K Buy
+14,000
New +$217K 0.06% 529

Other funds holding ORGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Campbell & Co Investment Adviser's ORGO Position: Q4 2022 in Review

Campbell & Co Investment Adviser sold out of Organogenesis Holdings (ORGO) in Q4 2022, closing a stake of 14,193 shares — an estimated $46K sold.

Campbell & Co Investment Adviser first reported a position in ORGO in Q3 2021 and held it in 4 quarters. The position peaked at $199K in Q3 2021. 150 funds tracked by Wall St. Rank hold ORGO as of Q4 2022.

  • Campbell & Co Investment Adviser reported no remaining Organogenesis Holdings position as of Q4 2022 after selling out during the quarter.
  • Campbell & Co Investment Adviser sold 14,193 Organogenesis Holdings shares in Q4 2022, an estimated $46K.
  • Campbell & Co Investment Adviser first reported a position in Organogenesis Holdings in Q3 2021 and held it in 4 quarters.
  • Campbell & Co Investment Adviser's Organogenesis Holdings position peaked at $199K in Q3 2021.
  • 150 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q4 2022.

Based on Campbell & Co Investment Adviser's 13F filing for Q4 2022, filed 14 Feb 2023.